{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:31:10Z","timestamp":1793647870014,"version":"4.5.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010301","name":"Oral and Maxillofacial Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oral squamous cell carcinoma (OSCC) is a capricious cancer with poor survival rates, even for early-stage patients. There is a pressing need to develop more precise risk assessment methods to appropriately tailor clinical treatment. Genome-wide association studies have not produced a viable biomarker. However, these studies are limited by using heterogeneous cohorts, not focusing on methylation although OSCC is a heavily epigenetically-regulated cancer, and not combining molecular data with clinicopathologic data for risk prediction. In this study we focused on early-stage (I\/II) OSCC and created a risk score called the REASON score, which combines clinicopathologic characteristics with a 12-gene methylation signature, to predict the risk of 5-year mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We combined data from an internal cohort (<jats:italic>n<\/jats:italic>\u2009=\u2009515) and The Cancer Genome Atlas (TCGA) cohort (<jats:italic>n<\/jats:italic>\u2009=\u200958). We collected clinicopathologic data from both cohorts to derive the non-molecular portion of the REASON score. We then analyzed the TCGA cohort DNA methylation data to derive the molecular portion of the risk score.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>5-year disease specific survival was 63% for the internal cohort and 86% for the TCGA cohort. The clinicopathologic features with the highest predictive ability among the two the cohorts were age, race, sex, tobacco use, alcohol use, histologic grade, stage, perineural invasion (PNI), lymphovascular invasion (LVI), and margin status. This panel of 10 non-molecular features predicted 5-year mortality risk with a concordance (c)-index\u2009=\u20090.67. Our molecular panel consisted of a 12-gene methylation signature (i.e., <jats:italic>HORMAD2, MYLK, GPR133, SOX8, TRPA1, ABCA2, HGFAC, MCPH1, WDR86, CACNA1H, RNF216, CCNJL<\/jats:italic>), which had the most significant differential methylation between patients who survived vs. died by 5\u2009years. All 12 genes have already been linked to survival in other cancers. Of the genes, only <jats:italic>SOX8<\/jats:italic> was previously associated with OSCC; our study was the first to link the remaining 11 genes to OSCC survival. The combined molecular and non-molecular panel formed the REASON score, which predicted risk of death with a c-index\u2009=\u20090.915.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The REASON score is a promising biomarker to predict risk of mortality in early-stage OSCC patients. Validation of the REASON score in a larger independent cohort is warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40364-021-00292-x","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T11:02:38Z","timestamp":1622890958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinoma"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5078-7807","authenticated-orcid":false,"given":"Chi T.","family":"Viet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesava","family":"Asam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carissa M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Chen","family":"Wongworawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Haghighiabyaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney A.","family":"Kilkuts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn M.","family":"McGue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus A.","family":"Couey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleen","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Grandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen C.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Philipone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia L.","family":"Ricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint T.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley E.","family":"Aouizerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,5]]},"reference":[{"key":"292_CR1","doi-asserted-by":"publisher","first-page":"i6369","DOI":"10.1136\/bmj.i6369","volume":"355","author":"A Gulland","year":"2016","unstructured":"Gulland A. Oral cancer rates rise by two thirds. BMJ. 2016;355:i6369.","journal-title":"BMJ"},{"key":"292_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.oraloncology.2017.02.019","volume":"67","author":"JE Tota","year":"2017","unstructured":"Tota JE, Anderson WF, Coffey C, Califano J, Cozen W, Ferris RL, et al. Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012. Oral Oncol. 2017;67:146\u201352. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.02.019.","journal-title":"Oral Oncol"},{"issue":"1","key":"292_CR3","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.1038\/s41598-020-64748-0","volume":"10","author":"YJ Kim","year":"2020","unstructured":"Kim YJ, Kim JH. Increasing incidence and improving survival of oral tongue squamous cell carcinoma. Sci Rep. 2020;10(1):7877. https:\/\/doi.org\/10.1038\/s41598-020-64748-0.","journal-title":"Sci Rep"},{"issue":"8","key":"292_CR4","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/hed.26089","volume":"42","author":"AJ Yoon","year":"2020","unstructured":"Yoon AJ, Wang S, Kutler DI, Carvajal RD, Philipone E, Wang T, et al. MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality. Head Neck. 2020;42(8):1699\u2013712. https:\/\/doi.org\/10.1002\/hed.26089.","journal-title":"Head Neck"},{"issue":"7","key":"292_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/(SICI)1097-0347(199710)19:7<583::AID-HED4>3.0.CO;2-3","volume":"19","author":"AP Yuen","year":"1997","unstructured":"Yuen AP, Wei WI, Wong YM, Tang KC. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck. 1997;19(7):583\u20138. https:\/\/doi.org\/10.1002\/(SICI)1097-0347(199710)19:7<583::AID-HED4>3.0.CO;2-3.","journal-title":"Head Neck"},{"issue":"4","key":"292_CR6","doi-asserted-by":"publisher","first-page":"2473974X1989112","DOI":"10.1177\/2473974X19891126","volume":"3","author":"AJ Yu","year":"2019","unstructured":"Yu AJ, Choi JS, Swanson MS, Kokot NC, Brown TN, Yan G, et al. Association of race\/ethnicity, stage, and survival in oral cavity squamous cell carcinoma: a SEER study. OTO Open. 2019;3(4):2473974X19891126.","journal-title":"OTO Open"},{"key":"292_CR7","doi-asserted-by":"publisher","first-page":"104770","DOI":"10.1016\/j.oraloncology.2020.104770","volume":"109","author":"CT Viet","year":"2020","unstructured":"Viet CT, Dierks EJ, Cheng AC, Patel AA, Chang SC, Couey MA, et al. Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: importance of nodal count in survival. Oral Oncol. 2020;109:104770. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104770.","journal-title":"Oral Oncol"},{"issue":"11","key":"292_CR8","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1158\/1078-0432.CCR-11-0044","volume":"17","author":"GM Poage","year":"2011","unstructured":"Poage GM, Houseman EA, Christensen BC, Butler RA, Avissar-Whiting M, McClean MD, et al. Global hypomethylation identifies loci targeted for hypermethylation in head and neck cancer. Clin Cancer Res. 2011;17(11):3579\u201389. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0044.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"292_CR9","first-page":"844","volume":"35","author":"CT Viet","year":"2007","unstructured":"Viet CT, Jordan RC, Schmidt BL. DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer. J Calif Dent Assoc. 2007;35(12):844\u20139.","journal-title":"J Calif Dent Assoc"},{"issue":"12","key":"292_CR10","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1158\/1055-9965.EPI-08-0507","volume":"17","author":"CT Viet","year":"2008","unstructured":"Viet CT, Schmidt BL. Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomark Prev. 2008;17(12):3603\u201311. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0507.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7","key":"292_CR11","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4161\/epi.29025","volume":"9","author":"R Guerrero-Preston","year":"2014","unstructured":"Guerrero-Preston R, Michailidi C, Marchionni L, Pickering CR, Frederick MJ, Myers JN, et al. Key tumor suppressor genes inactivated by \u201cgreater promoter\u201d methylation and somatic mutations in head and neck cancer. Epigenetics. 2014;9(7):1031\u201346. https:\/\/doi.org\/10.4161\/epi.29025.","journal-title":"Epigenetics"},{"issue":"1","key":"292_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(05)70540-4","volume":"7","author":"PK Ha","year":"2006","unstructured":"Ha PK, Califano JA. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol. 2006;7(1):77\u201382. https:\/\/doi.org\/10.1016\/S1470-2045(05)70540-4.","journal-title":"Lancet Oncol"},{"issue":"5","key":"292_CR13","first-page":"551","volume":"10","author":"MJ Huang","year":"2002","unstructured":"Huang MJ, Yeh KT, Shih HC, Wang YF, Lin TH, Chang JY, et al. The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas. Int J Mol Med. 2002;10(5):551\u20134.","journal-title":"Int J Mol Med"},{"issue":"8","key":"292_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.bjoms.2007.04.015","volume":"45","author":"RJ Shaw","year":"2007","unstructured":"Shaw RJ, Hall GL, Woolgar JA, Lowe D, Rogers SN, Field JK, et al. Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2007;45(8):617\u201322. https:\/\/doi.org\/10.1016\/j.bjoms.2007.04.015.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"4","key":"292_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/sj.bjc.6602972","volume":"94","author":"RJ Shaw","year":"2006","unstructured":"Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer. 2006;94(4):561\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6602972.","journal-title":"Br J Cancer"},{"issue":"1","key":"292_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/jmg.40.1.25","volume":"40","author":"DJ Smiraglia","year":"2003","unstructured":"Smiraglia DJ, Smith LT, Lang JC, Rush LJ, Dai Z, Schuller DE, et al. Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet. 2003;40(1):25\u201333. https:\/\/doi.org\/10.1136\/jmg.40.1.25.","journal-title":"J Med Genet"},{"issue":"6C","key":"292_CR17","first-page":"3971","volume":"22","author":"KT Yeh","year":"2002","unstructured":"Yeh KT, Shih MC, Lin TH, Chen JC, Chang JY, Kao CF, et al. The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma. Anticancer Res. 2002;22(6C):3971\u20135.","journal-title":"Anticancer Res"},{"issue":"3","key":"292_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/15592294.2015.1006506","volume":"10","author":"YF Li","year":"2015","unstructured":"Li YF, Hsiao YH, Lai YH, Chen YC, Chen YJ, Chou JL, et al. DNA methylation profiles and biomarkers of oral squamous cell carcinoma. Epigenetics. 2015;10(3):229\u201336. https:\/\/doi.org\/10.1080\/15592294.2015.1006506.","journal-title":"Epigenetics"},{"issue":"6871","key":"292_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van\u2019t Veer","year":"2002","unstructured":"van\u2019t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530\u20136. https:\/\/doi.org\/10.1038\/415530a.","journal-title":"Nature"},{"issue":"5","key":"292_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1634\/theoncologist.2007-0248","volume":"13","author":"JS Ross","year":"2008","unstructured":"Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobagyi GN. Commercialized multigene predictors of clinical outcome for breast cancer. Oncologist. 2008;13(5):477\u201393. https:\/\/doi.org\/10.1634\/theoncologist.2007-0248.","journal-title":"Oncologist"},{"issue":"2","key":"292_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3322\/caac.21389","volume":"67","author":"WM Lydiatt","year":"2017","unstructured":"Lydiatt WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et al. Head and neck cancers-major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122\u201337. https:\/\/doi.org\/10.3322\/caac.21389.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"292_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/epi.12.21","volume":"4","author":"N Touleimat","year":"2012","unstructured":"Touleimat N, Tost J. Complete pipeline for Infinium((R)) human methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics. 2012;4(3):325\u201341. https:\/\/doi.org\/10.2217\/epi.12.21.","journal-title":"Epigenomics"},{"issue":"10","key":"292_CR23","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btu049.","journal-title":"Bioinformatics"},{"issue":"7","key":"292_CR24","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"292_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25\u20139. https:\/\/doi.org\/10.1038\/75556.","journal-title":"Nat Genet"},{"key":"292_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/0470857897.ch8","volume":"247","author":"M Kanehisa","year":"2002","unstructured":"Kanehisa M. The KEGG database. Novartis Found Symp. 2002;247:91\u2013101 discussion 101\u20133, 119\u201328, 244\u201352.","journal-title":"Novartis Found Symp"},{"issue":"5","key":"292_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"292_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12859-016-0884-1","volume":"17","author":"L Geistlinger","year":"2016","unstructured":"Geistlinger L, Csaba G, Zimmer R. Bioconductor's EnrichmentBrowser: seamless navigation through combined results of set- & network-based enrichment analysis. BMC Bioinformatics. 2016;17:45.","journal-title":"BMC Bioinformatics"},{"key":"292_CR29","volume-title":"R Package: Homo.sapiens: Annotation package for the Homo.sapiens object. [1.3.1]","author":"Team BC","year":"2015","unstructured":"Team BC. R Package: Homo.sapiens: Annotation package for the Homo.sapiens object. [1.3.1] 2015."},{"issue":"10","key":"292_CR30","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.2015.11082","volume":"314","author":"MJ Pencina","year":"2015","unstructured":"Pencina MJ, D'Agostino RB Sr. Evaluating discrimination of Risk prediction models: the C statistic. JAMA. 2015;314(10):1063\u20134. https:\/\/doi.org\/10.1001\/jama.2015.11082.","journal-title":"JAMA"},{"issue":"19","key":"292_CR31","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1182\/blood-2011-04-345595","volume":"118","author":"LE Hogan","year":"2011","unstructured":"Hogan LE, Meyer JA, Yang J, Wang J, Wong N, Yang W, et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood. 2011;118(19):5218\u201326. https:\/\/doi.org\/10.1182\/blood-2011-04-345595.","journal-title":"Blood"},{"issue":"4","key":"292_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.canep.2014.03.013","volume":"38","author":"K Zhang","year":"2014","unstructured":"Zhang K, Tang S, Cao S, Hu L, Pan Y, Ma H, et al. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients. Cancer Epidemiol. 2014;38(4):414\u20138. https:\/\/doi.org\/10.1016\/j.canep.2014.03.013.","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"292_CR33","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/ng.875","volume":"43","author":"Z Hu","year":"2011","unstructured":"Hu Z, Wu C, Shi Y, Guo H, Zhao X, Yin Z, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet. 2011;43(8):792\u20136.","journal-title":"Nat Genet"},{"issue":"10","key":"292_CR34","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1111\/jcmm.13680","volume":"22","author":"Q Lin","year":"2018","unstructured":"Lin Q, Hou S, Guan F, Lin C. HORMAD2 methylation-mediated epigenetic regulation of gene expression in thyroid cancer. J Cell Mol Med. 2018;22(10):4640\u201352. https:\/\/doi.org\/10.1111\/jcmm.13680.","journal-title":"J Cell Mol Med"},{"key":"292_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.canlet.2017.06.027","volume":"403","author":"Z Zhong","year":"2017","unstructured":"Zhong Z, Huang M, Lv M, He Y, Duan C, Zhang L, et al. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA\/VEGFR2 signaling pathway. Cancer Lett. 2017;403:305\u201317. https:\/\/doi.org\/10.1016\/j.canlet.2017.06.027.","journal-title":"Cancer Lett"},{"issue":"5","key":"292_CR36","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3892\/or.2018.6324","volume":"39","author":"Y Xing","year":"2018","unstructured":"Xing Y, Zhao Z, Zhu Y, Zhao L, Zhu A, Piao D. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma. Oncol Rep. 2018;39(5):2365\u201375. https:\/\/doi.org\/10.3892\/or.2018.6324.","journal-title":"Oncol Rep"},{"issue":"8","key":"292_CR37","doi-asserted-by":"publisher","first-page":"13810","DOI":"10.1002\/jcb.28655","volume":"120","author":"J Ye","year":"2019","unstructured":"Ye J, Zhang J, Lv Y, Wei J, Shen X, Huang J, et al. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. J Cell Biochem. 2019;120(8):13810\u201325. https:\/\/doi.org\/10.1002\/jcb.28655.","journal-title":"J Cell Biochem"},{"issue":"10","key":"292_CR38","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1038\/oncsis.2016.63","volume":"5","author":"NS Bayin","year":"2016","unstructured":"Bayin NS, Frenster JD, Kane JR, Rubenstein J, Modrek AS, Baitalmal R, et al. GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth. Oncogenesis. 2016;5(10):e263. https:\/\/doi.org\/10.1038\/oncsis.2016.63.","journal-title":"Oncogenesis"},{"issue":"1","key":"292_CR39","first-page":"vdaa053","volume":"2","author":"JD Frenster","year":"2020","unstructured":"Frenster JD, Kader M, Kamen S, Sun J, Chiriboga L, Serrano J, et al. Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypes. Neurooncol Adv. 2020;2(1):vdaa053.","journal-title":"Neurooncol Adv"},{"issue":"6","key":"292_CR40","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/ijc.31134","volume":"142","author":"SL Xie","year":"2018","unstructured":"Xie SL, Fan S, Zhang SY, Chen WX, Li QX, Pan GK, et al. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt\/beta-catenin pathway. Int J Cancer. 2018;142(6):1252\u201365. https:\/\/doi.org\/10.1002\/ijc.31134.","journal-title":"Int J Cancer"},{"issue":"12","key":"292_CR41","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1080\/15384047.2020.1840318","volume":"21","author":"W Tian","year":"2020","unstructured":"Tian W, Li Z, Bai L, Chen L, Yan Y, Li H, et al. The oncogenic role of SOX8 in endometrial carcinoma. Cancer Biol Ther. 2020;21(12):1136\u201344. https:\/\/doi.org\/10.1080\/15384047.2020.1840318.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"292_CR42","first-page":"83","volume":"13","author":"YR Park","year":"2016","unstructured":"Park YR, Chun JN, So I, Kim HJ, Baek S, Jeon JH, et al. Data-driven analysis of TRP channels in Cancer: linking variation in gene expression to clinical significance. Cancer Genomics Proteomics. 2016;13(1):83\u201390.","journal-title":"Cancer Genomics Proteomics"},{"issue":"10","key":"292_CR43","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.7150\/jca.15326","volume":"7","author":"YT Wu","year":"2016","unstructured":"Wu YT, Yen SL, Li CF, Chan TC, Chen TJ, Lee SW, et al. Overexpression of transient receptor protein Cation Channel subfamily a member 1, confers an independent prognostic Indicator in nasopharyngeal carcinoma. J Cancer. 2016;7(10):1181\u20138. https:\/\/doi.org\/10.7150\/jca.15326.","journal-title":"J Cancer"},{"issue":"4","key":"292_CR44","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3892\/or.2016.4599","volume":"35","author":"K Elsnerova","year":"2016","unstructured":"Elsnerova K, Mohelnikova-Duchonova B, Cerovska E, Ehrlichova M, Gut I, Rob L, et al. Gene expression of membrane transporters: importance for prognosis and progression of ovarian carcinoma. Oncol Rep. 2016;35(4):2159\u201370. https:\/\/doi.org\/10.3892\/or.2016.4599.","journal-title":"Oncol Rep"},{"issue":"1","key":"292_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4161\/cbt.26603","volume":"15","author":"S Rahgozar","year":"2014","unstructured":"Rahgozar S, Moafi A, Abedi M, Entezar EGM, Moshtaghian J, Ghaedi K, et al. mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2. Cancer Biol Ther. 2014;15(1):35\u201341. https:\/\/doi.org\/10.4161\/cbt.26603.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"292_CR46","doi-asserted-by":"publisher","first-page":"9692","DOI":"10.1002\/jcb.28247","volume":"120","author":"L Yin","year":"2019","unstructured":"Yin L, Mu Y, Lin Y, Xia Q. HGFAC expression decreased in liver cancer and its low expression correlated with DNA hypermethylation and poor prognosis. J Cell Biochem. 2019;120(6):9692\u20139. https:\/\/doi.org\/10.1002\/jcb.28247.","journal-title":"J Cell Biochem"},{"issue":"1","key":"292_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-4608(01)00386-7","volume":"128","author":"J Tapper","year":"2001","unstructured":"Tapper J, Kettunen E, El-Rifai W, Seppala M, Andersson LC, Knuutila S. Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet. 2001;128(1):1\u20136. https:\/\/doi.org\/10.1016\/S0165-4608(01)00386-7.","journal-title":"Cancer Genet Cytogenet"},{"key":"292_CR48","doi-asserted-by":"publisher","first-page":"e923559","DOI":"10.12659\/MSM.923559","volume":"26","author":"Y Qiang","year":"2020","unstructured":"Qiang Y, Feng L, Wang G, Liu J, Zhang J, Xiang L, et al. miR-20a\/Foxj2 Axis Mediates Growth and Metastasis of Colorectal Cancer Cells as Identified by Integrated Analysis. Med Sci Monit. 2020;26:e923559.","journal-title":"Med Sci Monit"},{"issue":"1","key":"292_CR49","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13058-020-01299-2","volume":"22","author":"X Gu","year":"2020","unstructured":"Gu X, Wang B, Zhu H, Zhou Y, Horning AM, Huang TH, et al. Age-associated genes in human mammary gland drive human breast cancer progression. Breast Cancer Res. 2020;22(1):64. https:\/\/doi.org\/10.1186\/s13058-020-01299-2.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"292_CR50","doi-asserted-by":"publisher","first-page":"e0182818","DOI":"10.1371\/journal.pone.0182818","volume":"12","author":"L Fornaro","year":"2017","unstructured":"Fornaro L, Vivaldi C, Lin D, Xue H, Falcone A, Wang Y, et al. Prognostic relevance of a T-type calcium channels gene signature in solid tumours: a correlation ready for clinical validation. PLoS One. 2017;12(8):e0182818. https:\/\/doi.org\/10.1371\/journal.pone.0182818.","journal-title":"PLoS One"},{"issue":"32","key":"292_CR51","doi-asserted-by":"publisher","first-page":"51174","DOI":"10.18632\/oncotarget.9433","volume":"7","author":"H Wang","year":"2016","unstructured":"Wang H, Wang Y, Qian L, Wang X, Gu H, Dong X, et al. RNF216 contributes to proliferation and migration of colorectal cancer via suppressing BECN1-dependent autophagy. Oncotarget. 2016;7(32):51174\u201383. https:\/\/doi.org\/10.18632\/oncotarget.9433.","journal-title":"Oncotarget"},{"issue":"3","key":"292_CR52","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.3892\/ol.2017.6552","volume":"14","author":"R Guan","year":"2017","unstructured":"Guan R, Cai S, Sun M, Xu M. Upregulation of miR-520b promotes ovarian cancer growth. Oncol Lett. 2017;14(3):3155\u201361. https:\/\/doi.org\/10.3892\/ol.2017.6552.","journal-title":"Oncol Lett"},{"key":"292_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/JHC.S272109","volume":"7","author":"B Hu","year":"2020","unstructured":"Hu B, Yang XB, Sang XT. Development and verification of the hypoxia-related and immune-associated prognosis signature for hepatocellular carcinoma. J Hepatocell Carcinoma. 2020;7:315\u201330. https:\/\/doi.org\/10.2147\/JHC.S272109.","journal-title":"J Hepatocell Carcinoma"},{"issue":"5","key":"292_CR54","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.trecan.2020.02.007","volume":"6","author":"J Smith","year":"2020","unstructured":"Smith J, Sen S, Weeks RJ, Eccles MR, Chatterjee A. Promoter DNA Hypermethylation and paradoxical gene activation. Trends Cancer. 2020;6(5):392\u2013406. https:\/\/doi.org\/10.1016\/j.trecan.2020.02.007.","journal-title":"Trends Cancer"},{"issue":"6","key":"292_CR55","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1056\/NEJMoa052933","volume":"355","author":"C Fan","year":"2006","unstructured":"Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006;355(6):560\u20139. https:\/\/doi.org\/10.1056\/NEJMoa052933.","journal-title":"N Engl J Med"},{"issue":"17","key":"292_CR56","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1002\/cncr.31638","volume":"124","author":"F Guo","year":"2018","unstructured":"Guo F, Kuo YF, Shih YCT, Giordano SH, Berenson AB. Trends in breast cancer mortality by stage at diagnosis among young women in the United States. Cancer. 2018;124(17):3500\u20139. https:\/\/doi.org\/10.1002\/cncr.31638.","journal-title":"Cancer"},{"issue":"4","key":"292_CR57","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1634\/theoncologist.2012-0458","volume":"18","author":"MH Cohen","year":"2013","unstructured":"Cohen MH, Chen H, Shord S, Fuchs C, He K, Zhao H, et al. Approval summary: Cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer. Oncologist. 2013;18(4):460\u20136. https:\/\/doi.org\/10.1634\/theoncologist.2012-0458.","journal-title":"Oncologist"},{"key":"292_CR58","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1479-5876-10-205","volume":"10","author":"J Galon","year":"2012","unstructured":"Galon J, Pages F, Marincola FM, Angell HK, Thurin M, Lugli A, et al. Cancer classification using the Immunoscore: a worldwide task force. J Transl Med. 2012;10:205.","journal-title":"J Transl Med"},{"key":"292_CR59","doi-asserted-by":"publisher","unstructured":"Kather JN, Suarez-Carmona M, Charoentong P, Weis CA, Hirsch D, Bankhead P, et al. Topography of cancer-associated immune cells in human solid tumors. Elife. 2018;7. https:\/\/doi.org\/10.7554\/eLife.36967.","DOI":"10.7554\/eLife.36967"},{"issue":"7","key":"292_CR60","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/archotol.1994.01880310005001","volume":"120","author":"MH Weiss","year":"1994","unstructured":"Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994;120(7):699\u2013702. https:\/\/doi.org\/10.1001\/archotol.1994.01880310005001.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"3","key":"292_CR61","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.coms.2008.02.002","volume":"20","author":"A Cheng","year":"2008","unstructured":"Cheng A, Schmidt BL. Management of the N0 neck in oral squamous cell carcinoma. Oral Maxillofac Surg Clin North Am. 2008;20(3):477\u201397. https:\/\/doi.org\/10.1016\/j.coms.2008.02.002.","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"6","key":"292_CR62","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1056\/NEJMoa1506007","volume":"373","author":"AK D'Cruz","year":"2015","unstructured":"D'Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, et al. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer. N Engl J Med. 2015;373(6):521\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1506007.","journal-title":"N Engl J Med"},{"issue":"33","key":"292_CR63","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1200\/JCO.2011.40.4509","volume":"30","author":"SR van Hooff","year":"2012","unstructured":"van Hooff SR, Leusink FK, Roepman P, de Jong RJB, Speel EJ, van den Brekel MW, et al. Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. J Clin Oncol. 2012;30(33):4104\u201310. https:\/\/doi.org\/10.1200\/JCO.2011.40.4509.","journal-title":"J Clin Oncol"},{"issue":"4","key":"292_CR64","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1158\/0008-5472.CAN-05-3960","volume":"66","author":"P Roepman","year":"2006","unstructured":"Roepman P, Kemmeren P, Wessels LF, Slootweg PJ, Holstege FC. Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res. 2006;66(4):2361\u20136. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3960.","journal-title":"Cancer Res"},{"issue":"2","key":"292_CR65","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/ng1502","volume":"37","author":"P Roepman","year":"2005","unstructured":"Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet. 2005;37(2):182\u20136. https:\/\/doi.org\/10.1038\/ng1502.","journal-title":"Nat Genet"},{"issue":"26","key":"292_CR66","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.1038\/sj.onc.1208601","volume":"24","author":"AM Snijders","year":"2005","unstructured":"Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, Jordan RC, et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene. 2005;24(26):4232\u201342. https:\/\/doi.org\/10.1038\/sj.onc.1208601.","journal-title":"Oncogene"},{"issue":"6046","key":"292_CR67","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.1208130","volume":"333","author":"N Stransky","year":"2011","unstructured":"Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157\u201360.","journal-title":"Science"},{"issue":"22","key":"292_CR68","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1158\/1078-0432.CCR-11-1944","volume":"17","author":"A Bhattacharya","year":"2011","unstructured":"Bhattacharya A, Roy R, Snijders AM, Hamilton G, Paquette J, Tokuyasu T, et al. Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis. Clin Cancer Res. 2011;17(22):7024\u201334. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1944.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"292_CR69","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1038\/oncsis.2015.7","volume":"4","author":"SS Chauhan","year":"2015","unstructured":"Chauhan SS, Kaur J, Kumar M, Matta A, Srivastava G, Alyass A, et al. Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer. Oncogenesis. 2015;4(4):e147. https:\/\/doi.org\/10.1038\/oncsis.2015.7.","journal-title":"Oncogenesis"},{"key":"292_CR70","first-page":"654","volume-title":"Pattern classification","author":"RO Duda","year":"2001","unstructured":"Duda RO, Hart PE, Stork DG. Pattern classification. 2nd ed. New York: Wiley; 2001. p. 654.","edition":"2"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-021-00292-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-021-00292-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-021-00292-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T11:05:32Z","timestamp":1622891132000},"score":1,"resource":{"primary":{"URL":"https:\/\/biomarkerres.biomedcentral.com\/articles\/10.1186\/s40364-021-00292-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,5]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1186\/s40364-021-00292-x","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,5]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was obtained to create the de-identified patient databases at each respective institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}